1-4 of 4
Thierry Abribat, PhD
Close
Sort by
Journal Articles

Anti-Leukemic Activity of a Novel Pegylated Recombinant Erwinia Chrysanthemi -Derived L-Asparaginase On Lymphoid Cell Lines and Leukemia-Bearing Mouse Models.

Wei-Wen Chien, PhD, CeĢline Lebeux, Nicolas Rachinel, PhD, Soraya Allas, MD, PhD, Pierre Sahakian, Pharm PhD, Michel Julien, PhD, Claire Lacroix, Thierry Abribat, PhD, Gilles Salles, MD
Journal: Blood
Blood (2012) 120 (21): 2571.
https://doi.org/10.1182/blood.V120.21.2571.2571
Published: 2012
Journal Articles

Pharmacokinetics and Pharmacodynamics in Mice of a Pegylated Recombinant Erwinia Chrysanthemi -Derived L-Asparaginase.

Soraya Allas, MD, PhD, Pierre Sahakian, PharmD, Iduna Fichtner, PhD, Thierry Abribat, PhD
Journal: Blood
Blood (2009) 114 (22): 2033.
https://doi.org/10.1182/blood.V114.22.2033.2033
Published: 2009
Journal Articles

Immunogenicity Profile in Mice of a Pegylated Recombinant Erwinia Chrysanthemi -Derived L-Asparaginase.

Soraya Allas, MD, PhD, Pierre Sahakian, PharmD, Iduna Fichtner, PhD, Thierry Abribat, PhD
Journal: Blood
Blood (2009) 114 (22): 2034.
https://doi.org/10.1182/blood.V114.22.2034.2034
Published: 2009
Journal Articles

In Vitro Characterization of OP-R003-1, a New Fully Human Anti-IL6 Antibody.

Claudine Vermot-Desroches, PhD, Wei Wang, PhD, Olivier Subiger, Thierry Abribat, PhD, Gilles Alberici, PhD, Maurice Zauderer, PhD, Smith Ernest, PhD
Journal: Blood
Blood (2007) 110 (11): 4522.
https://doi.org/10.1182/blood.V110.11.4522.4522
Published: 2007